The PA news agency looks at which sectors will be most affected by the plans and what it means for businesses and households.
Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback